Efficacy of maropitant in the prevention of delayed vomiting associated with administration of doxorubicin to dogs.
Rau
S E
SE
Harrington Oncology Program, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA, USA. srau13@hotmail.com
Barber
L G
LG
Burgess
K E
KE
D000818:Animals; D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004283:Dog Diseases / Q000139:chemically induced* / Q000517:prevention & control; D004285:Dogs; D004317:Doxorubicin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D008297:Male; D009369:Neoplasms / Q000188:drug therapy; D011812:Quinuclidines / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control / Q000662:veterinary*
D000932:Antiemetics; D000970:Antineoplastic Agents; D011812:Quinuclidines; C518176:maropitant; D004317:Doxorubicin